Ruxolitinib treatment for SR-aGVHD in patients with EBV-HLH undergoing allo-HSCT

Meng, GQ; Wang, JS; Wang, XK; Wang, YN; Wang, Z

Wang, Z (reprint author), Capital Med Univ, Beijing Friendship Hosp, Dept Hematol, Beijing, Peoples R China.

ANNALS OF HEMATOLOGY, 0; ():

Abstract

Ruxolitinib is a promising option for treating steroid-refractory acute graft-versus-host disease (SR-aGVHD) after allogeneic hematopoietic stem cell ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索